Next-Generation Sequencing (NGS)

Next-Generation Sequencing (NGS) is an advanced genetic testing technology that plays a vital role in modern precision oncology. It helps identify specific genetic mutations, molecular alterations, and biomarkers within cancer cells, allowing doctors to develop highly personalized treatment strategies. Dr. Darshit K Shah utilizes NGS as part of a precision medicine approach to ensure patients receive the most effective and targeted cancer therapies based on the unique genetic profile of their tumor.

Traditional cancer treatments are often based on the location and type of cancer, whereas NGS provides deeper insights into the molecular characteristics of the disease. By analyzing multiple genes simultaneously, this advanced technology can identify actionable mutations that may respond to targeted therapies, immunotherapy, or other specialized treatment options. This enables a more individualized and effective approach to cancer care.

Dr. Shah carefully interprets NGS reports and integrates the findings into a comprehensive treatment plan. The information obtained through NGS can help guide treatment selection, identify clinical trial opportunities, predict treatment response, and support better decision-making throughout the cancer journey. This approach is particularly valuable for advanced, recurrent, and difficult-to-treat cancers.

Dr. Darshit K Shah combines expertise in precision oncology and molecular medicine to help patients benefit from Next-Generation Sequencing, enabling highly personalized cancer treatment strategies aimed at achieving better outcomes and improved quality of life.